J DAVID MOORE

Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry GREENVILLE, SC NPI 1497767792

General Payments — all program years on this page

$4,541.80

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 149
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $634.22 across 15 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $634.2215

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $686.4223
2019 $1,081.7425
2020 $498.4420
2021 $424.5223
2022 $527.2724
2023 $689.1919
2024 $634.2215

Records — PY2024 (15)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078176899 Janssen Pharmaceuticals, Inc $15.60 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105059964 ABBVIE INC. $25.09 04/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118945381 Otsuka America Pharmaceutical, Inc. $108.94 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137637982 Takeda Pharmaceuticals U.S.A., Inc. $19.95 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137637984 Takeda Pharmaceuticals U.S.A., Inc. $20.49 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137637986 Takeda Pharmaceuticals U.S.A., Inc. $25.73 07/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137637988 Takeda Pharmaceuticals U.S.A., Inc. $22.27 08/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137637990 Takeda Pharmaceuticals U.S.A., Inc. $22.27 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145947884 Lundbeck LLC $16.76 08/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146778179 IDORSIA PHARMACEUTICALS US INC $14.19 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146782502 IDORSIA PHARMACEUTICALS US INC $93.63 11/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147893669 Supernus Pharmaceuticals, Inc. $128.17 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148286187 Axsome Therapeutics, Inc. $18.36 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148286189 Axsome Therapeutics, Inc. $82.38 01/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148286191 Axsome Therapeutics, Inc. $20.39 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.